Methylation of Stat1 promoter can contribute to squamous cell carcinogenesis

Journal of the National Cancer Institute

Volumn 98, Issue 3, 2006, Pages 154-155

  Lee, Heehyoung ^a   Yu, Hua ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOKINE; GROWTH FACTOR; INTERFERON; PROTEIN P21; PROTEIN TYROSINE KINASE; STAT1 PROTEIN; STAT3 PROTEIN;

APOPTOSIS; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CPG ISLAND; DNA DAMAGE; DNA METHYLATION; EDITORIAL; ENZYME ACTIVATION; GENE ACTIVATION; GENE SILENCING; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR BINDING; RETINOBLASTOMA; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; VON HIPPEL LINDAU DISEASE;

CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; HEAD AND NECK NEOPLASMS; HUMANS; PROMOTER REGIONS (GENETICS); STAT TRANSCRIPTION FACTORS; STAT1 TRANSCRIPTION FACTOR;

EID: 32144457695     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djj038     Document Type: Editorial

References (20)

1. Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto Y, Fu XY. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21WAF1/CIP1 mediated by STAT1. Science 1996;272:719-22.
2. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 1998;95: 7556-61.
3. Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE Jr. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci U S A 1996;93:7673-8.
4. Huang S, Bucana CD, Arsdall MV, Fidler IJ. Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene 2002;21:2504-12.
5. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997;17:5328-37.
6. Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, et al. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Invest 1998;102:1385-92.
7. Xi S, Zhang Q, Gooding WE, Smithgall TE, Grandis JR. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Cancer Res 2003;63:6763-71.
8. Yu H, Jove R. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 2004;4:97-105.
9. Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, et al. Constitutive activation of stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A 2000;97:4227-32.
10. Xi S, Dyer KF, Kimak M, Zhang Q, Gooding WE, Chaillet JR, et al. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst 2006;98:181-9.
11. Townsend PA, Cragg MS, Davidson SM, McCormick J, Barry S, Lawrence KM, et al. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage. J Cell Sci 2005;118:1629-39.
12. Townsend PA, Scarabelli TM, Davidson SM, Knight RA, Latchman DS, Stephanou A. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem 2004;279:5811-20.
13. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10: 39-49.
14. Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, et al. Inhibition of Stat3 signaling in the hematopoietic system elicits multi-component antitumor immunity. Nat Med 2005;11:1314-21.
15. Shen Y, Devgan G, Darnell JE Jr, Bromberg JF. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci U S A 2001;98:1543-8.
16. Robertson KD. DNA methylation, methyltransferase, and cancer. Oncogene 2001;20:3139-55.
17. Greger V, Passarge E, Hopping W, Messmer E, Horsthemke B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 1989;83:155-8.
18. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994;91:9700-4.
19. Galm O, Yoshikawa H, Esteller M, Osieka R, Herman JG. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 2003;101:2784-8.
20. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 2005;45:629-56.